ENTITY

Clover Biopharmaceuticals (2197 HK)

Analysis

Health Care • China

Clover Biopharmaceuticals Limited operates as a clinical-stage biotechnology company. The Company develops novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases. Clover Biopharmaceuticals provides services worldwide.

Refresh

No presentations found

We’ll display presentations we find for Clover Biopharmaceuticals here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00